Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000942794-99-000007
Filing Date
1999-04-08
Accepted
1999-04-08 00:00:00
Documents
1
Period of Report
1999-04-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A 54213
  Complete submission text file 0000942794-99-000007.txt   55856
Mailing Address 365 PLANTATION STREET WORCESTER MA 01605
Business Address 175 CROSSING BLVD BIOTECHNOLOGY RESEARCH PARK FRAMINGHAM MA 01605 5087975777
AQUILA BIOPHARMACEUTICALS INC (Filer) CIK: 0000704292 (see all company filings)

EIN.: 043307818 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-12081 | Film No.: 99589224
SIC: 2835 In Vitro & In Vivo Diagnostic Substances